| 000 | 01376 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515161813.0 | ||
| 264 | 0 | _c20090422 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2009.12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, C M | |
| 245 | 0 | 0 |
_aVHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo. _h[electronic resource] |
| 260 |
_bOncogene _cApr 2009 |
||
| 300 |
_a1694-705 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBasic Helix-Loop-Helix Transcription Factors _xphysiology |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xphysiology |
| 650 | 0 | 4 |
_aKidney Neoplasms _xetiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aTeratoma _xblood supply |
| 650 | 0 | 4 |
_aVon Hippel-Lindau Tumor Suppressor Protein _xgenetics |
| 700 | 1 | _aHickey, M M | |
| 700 | 1 | _aSanford, C A | |
| 700 | 1 | _aMcGuire, C G | |
| 700 | 1 | _aCowey, C L | |
| 700 | 1 | _aSimon, M C | |
| 700 | 1 | _aRathmell, W K | |
| 773 | 0 |
_tOncogene _gvol. 28 _gno. 14 _gp. 1694-705 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2009.12 _zAvailable from publisher's website |
| 999 |
_c18693723 _d18693723 |
||